MXPA05012253A - Suministro intravenoso de polinucleotidos a celulas en extremidades de mamiferos. - Google Patents
Suministro intravenoso de polinucleotidos a celulas en extremidades de mamiferos.Info
- Publication number
- MXPA05012253A MXPA05012253A MXPA05012253A MXPA05012253A MXPA05012253A MX PA05012253 A MXPA05012253 A MX PA05012253A MX PA05012253 A MXPA05012253 A MX PA05012253A MX PA05012253 A MXPA05012253 A MX PA05012253A MX PA05012253 A MXPA05012253 A MX PA05012253A
- Authority
- MX
- Mexico
- Prior art keywords
- polynucleotides
- cells
- limb
- intravenous delivery
- delivery
- Prior art date
Links
- 102000040430 polynucleotide Human genes 0.000 title abstract 4
- 108091033319 polynucleotide Proteins 0.000 title abstract 4
- 239000002157 polynucleotide Substances 0.000 title abstract 4
- 238000001990 intravenous administration Methods 0.000 title abstract 2
- 238000002347 injection Methods 0.000 abstract 2
- 239000007924 injection Substances 0.000 abstract 2
- 206010015866 Extravasation Diseases 0.000 abstract 1
- 238000002716 delivery method Methods 0.000 abstract 1
- 230000036251 extravasation Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 210000003462 vein Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0083—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invencion se refiere a un metodo para el suministro intravenoso, que es capaz de suministrar polinucleotidos a celulas extravasculares de una extremidad de mamifero. El metodo involucra la inyeccion de polinucleotidos en una vena distal de una extremidad que es ocluida temporalmente. El suministro del polinucleotido es facilitado por la inyeccion rapida en un volumen suficiente para permitir la extravasacion de la solucion en el tejido circundante.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47365403P | 2003-05-28 | 2003-05-28 | |
US50021103P | 2003-09-04 | 2003-09-04 | |
US10/855,175 US7803782B2 (en) | 2003-05-28 | 2004-05-27 | Intravenous delivery of polynucleotides to cells in mammalian limb |
PCT/US2004/017000 WO2004105836A2 (en) | 2003-05-28 | 2004-05-28 | Intravenous delivery of polynucleotides to cells in mammalian limb |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05012253A true MXPA05012253A (es) | 2006-02-10 |
Family
ID=33458804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05012253A MXPA05012253A (es) | 2003-05-28 | 2004-05-28 | Suministro intravenoso de polinucleotidos a celulas en extremidades de mamiferos. |
Country Status (7)
Country | Link |
---|---|
US (1) | US7803782B2 (es) |
EP (1) | EP1626755A4 (es) |
JP (1) | JP2007501282A (es) |
AU (1) | AU2004242978B2 (es) |
CA (1) | CA2527303A1 (es) |
MX (1) | MXPA05012253A (es) |
WO (1) | WO2004105836A2 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7642248B2 (en) * | 1999-11-05 | 2010-01-05 | Roche Madison Inc | Devices and processes for distribution of genetic material to mammalian limb |
US6784291B2 (en) | 2000-05-04 | 2004-08-31 | Avi Biopharma, Inc. | Splice-region antisense composition and method |
US20060115462A1 (en) * | 2004-12-01 | 2006-06-01 | Vladimir Subbotin | Direct DNA delivery to bone cells |
AU2006213686A1 (en) * | 2005-02-09 | 2006-08-17 | Avi Bio Pharma, Inc. | Antisense composition and method for treating muscle atrophy |
AU2015203791B2 (en) * | 2005-02-09 | 2017-06-29 | Sarepta Therapeutics, Inc. | Antisense composition and method for treating |
AU2013201250B2 (en) * | 2005-02-09 | 2015-04-30 | Sarepta Therapeutics, Inc. | Antisense composition and method for treating muscle atrophy |
JP2009519339A (ja) | 2005-12-12 | 2009-05-14 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 筋細胞増殖及び分化を調節するマイクロrna |
WO2008127654A2 (en) * | 2007-04-11 | 2008-10-23 | The University Of North Carolina At Chapel Hill | Methods and compositions for intra-articular coagulation proteins |
US20130085139A1 (en) | 2011-10-04 | 2013-04-04 | Royal Holloway And Bedford New College | Oligomers |
US20150328249A1 (en) * | 2012-12-11 | 2015-11-19 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Modulation of myofiber repair by anti-myostatin strategies and/or ppar gamma ligands, alone or in combination with stem cells, for the therapy of critical limb ischemia and other ischemic processes affecting the skeletal muscle |
US9752143B2 (en) | 2013-03-15 | 2017-09-05 | MiRagen Therapeutics, Inc. | Locked nucleic acid inhibitor of miR-145 and uses thereof |
MA41795A (fr) | 2015-03-18 | 2018-01-23 | Sarepta Therapeutics Inc | Exclusion d'un exon induite par des composés antisens dans la myostatine |
WO2017180279A2 (en) * | 2016-04-15 | 2017-10-19 | Thegents Of The University Of Michigan | Assistive device for subcutaneous injections or implants |
WO2019096325A1 (zh) * | 2017-11-20 | 2019-05-23 | 江苏达骏生物科技有限公司 | 一种双酰胺复合物及其制备方法和用途 |
CN109886600B (zh) * | 2019-03-06 | 2021-04-27 | 绍兴文理学院 | 监测预警煤层分叉合并区冲击地压危险性的方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5703055A (en) * | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5698531A (en) * | 1989-03-31 | 1997-12-16 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
US5521291A (en) * | 1991-09-30 | 1996-05-28 | Boehringer Ingelheim International, Gmbh | Conjugates for introducing nucleic acid into higher eucaryotic cells |
US5583020A (en) * | 1992-11-24 | 1996-12-10 | Ribozyme Pharmaceuticals, Inc. | Permeability enhancers for negatively charged polynucleotides |
US5922687A (en) * | 1995-05-04 | 1999-07-13 | Board Of Trustees Of The Leland Stanford Junior University | Intracellular delivery of nucleic acids using pressure |
US5744335A (en) * | 1995-09-19 | 1998-04-28 | Mirus Corporation | Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein |
US6627616B2 (en) | 1995-12-13 | 2003-09-30 | Mirus Corporation | Intravascular delivery of non-viral nucleic acid |
US6265387B1 (en) * | 1995-10-11 | 2001-07-24 | Mirus, Inc. | Process of delivering naked DNA into a hepatocyte via bile duct |
JP3813669B2 (ja) * | 1995-10-27 | 2006-08-23 | 松下電器産業株式会社 | 端末装置及び端末装置の能力情報通知方法 |
US6177403B1 (en) * | 1996-10-21 | 2001-01-23 | The Trustees Of The University Of Pennsylvania | Compositions, methods, and apparatus for delivery of a macromolecular assembly to an extravascular tissue of an animal |
DE69738316T2 (de) * | 1997-06-20 | 2008-09-25 | Mirus Bio Corp., Madison | Verfahren zur verabreichung eines polynukleotids über das gefä system |
CA2290736A1 (en) * | 1997-07-11 | 1999-01-21 | Introgene B.V. | Interleukin-3 gene therapy for cancer |
US6699231B1 (en) * | 1997-12-31 | 2004-03-02 | Heartport, Inc. | Methods and apparatus for perfusion of isolated tissue structure |
EP1209971A4 (en) | 1999-08-20 | 2004-04-14 | Mirus Corp | POLYION COMPLEX LOAD INVERSION |
US7214369B2 (en) * | 2003-05-05 | 2007-05-08 | Mirus Bio Corporation | Devices and processes for distribution of genetic material to mammalian limb |
US20040136960A1 (en) * | 2003-01-10 | 2004-07-15 | Wolff Jon A. | Devices and processes for distribution of genetic material to mammalian limb |
-
2004
- 2004-05-27 US US10/855,175 patent/US7803782B2/en active Active
- 2004-05-28 AU AU2004242978A patent/AU2004242978B2/en not_active Ceased
- 2004-05-28 WO PCT/US2004/017000 patent/WO2004105836A2/en active IP Right Grant
- 2004-05-28 CA CA002527303A patent/CA2527303A1/en not_active Abandoned
- 2004-05-28 MX MXPA05012253A patent/MXPA05012253A/es not_active Application Discontinuation
- 2004-05-28 JP JP2006533508A patent/JP2007501282A/ja active Pending
- 2004-05-28 EP EP04753760A patent/EP1626755A4/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
US20040242528A1 (en) | 2004-12-02 |
AU2004242978A1 (en) | 2004-12-09 |
WO2004105836A3 (en) | 2006-02-02 |
AU2004242978B2 (en) | 2007-05-31 |
JP2007501282A (ja) | 2007-01-25 |
US7803782B2 (en) | 2010-09-28 |
CA2527303A1 (en) | 2004-12-09 |
WO2004105836A2 (en) | 2004-12-09 |
EP1626755A4 (en) | 2008-01-23 |
EP1626755A2 (en) | 2006-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05012253A (es) | Suministro intravenoso de polinucleotidos a celulas en extremidades de mamiferos. | |
RU2014106788A (ru) | Устройство и способ для инъекций | |
MXPA05000155A (es) | Dispositivo de electroporacion y aparato de inyeccion. | |
WO2004011060A3 (en) | Delivery of molecules and complexes to mammalian cells in vivo | |
WO2003070296A3 (en) | Injector with bypass channel | |
EA200301307A1 (ru) | Усиленное системное всасывание веществ, введённых интрадермальным путём | |
WO2006020255A3 (en) | Apparatus and methods for treating tissue using passive injection systems | |
GB2461213A (en) | Dual syringe assembly | |
CN203898862U (zh) | 免针注射正压接头装置 | |
CN204655622U (zh) | 一种乳腺引流清洗治疗仪 | |
CN208582855U (zh) | 一种同比例液体混合注射器 | |
TW200503630A (en) | Needleless injection device and method of injecting | |
GB2467244A (en) | Intravenous injection aid | |
CN201244257Y (zh) | 多针注射器 | |
CN204121509U (zh) | 一种正压无针连接件 | |
CN205339108U (zh) | 多针穿刺架及多针穿刺装置 | |
CN202654515U (zh) | 集麻醉与扩张于一体的尿道麻醉注药器 | |
CN207768849U (zh) | 介入科造影剂辅助推注器 | |
CN202122757U (zh) | 新型介入导管 | |
CN213131321U (zh) | 一种肝素注射装置 | |
CN2568216Y (zh) | 新型介入导管 | |
CN201543042U (zh) | 一次性使用输液器进针限定及防动针头 | |
CN110464982A (zh) | 一种负正压力注射器 | |
US20240009399A1 (en) | Needleless skin deep filler injection device | |
CN215821971U (zh) | 一种用于高压注射器的针筒抽杆结构 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |